Steve Sosnick, Interactive Brokers’ chief strategist, discusses how options trading and the outsized impact of Tesla (TSLA) are skewing stock market activity.
We really got ahead of ourselves, according to Sosnick.
Are investors only looking at upside and not considering the downside? Sosnick explains the current market dynamics and what to look for going forward.
Photo Credit: Zooey via Flickr Creative Commons
In June, the American Society of Clinical Oncology (ASCO) hosted its 60th Annual Meeting, drawing over 40,000 attendees from around the globe. This year’s event largely focused on validating revolutionary treatment categories like Chimeric antigen receptor (CAR) T-cell therapies and antibody drug conjugates (ADCs). Given proven clinical benefits across a wider array of cancer types, we expect these novel treatment categories to become increasingly important in the fight against cancer and the growth profiles of select companies in the healthcare space.
Market bets are rising this week that Europe could embark on a major bond-buying program with potential implications for U.S. stocks. Here’s what could happen:
There have been some big changes in our portfolio this last month.
The housing recovery offers attractive opportunities for investors.
